Tertiary Nav - Press Releases Press ReleasesMedia Statements Press Releases Items Per Page 102550 News Category Business & FinancialCitizenshipEarningsMedia StatementProduct NewsRecognitionRegulatoryScience & Innovation Year None2021202020192018201720162015201420132012201120102009200820072006 Date Title 9/3/19 Sarepta Therapeutics to Present at the Morgan Stanley 17th Annual Global Healthcare Conference 8/30/19 Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) 8/19/19 Sarepta Therapeutics Receives Complete Response Letter from the US Food and Drug Administration for Golodirsen New Drug Application 8/8/19 Sarepta Therapeutics Comments on Erroneous Submission to US FDA Adverse Event Reporting System (FAERS) 8/7/19 Sarepta Therapeutics Announces Second Quarter 2019 Financial Results and Recent Corporate Developments 7/31/19 Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) 7/31/19 Sarepta Therapeutics to Announce Second Quarter 2019 Financial Results and Recent Corporate Developments on August 7, 2019 6/28/19 Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) 6/4/19 Sarepta Therapeutics to Present at the Goldman Sachs 40th Annual Global Healthcare Conference 5/31/19 Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Pagination First page « first Previous page ‹ previous … Page 5 Page 6 Page 7 Page 8 Current page 9 Page 10 Page 11 Page 12 Page 13 … Next page next › Last page last » Displaying 81 - 90 of 670 Toolkit Print Page | Email Alerts | RSS Feeds | Contacts
Press Releases Items Per Page 102550 News Category Business & FinancialCitizenshipEarningsMedia StatementProduct NewsRecognitionRegulatoryScience & Innovation Year None2021202020192018201720162015201420132012201120102009200820072006 Date Title 9/3/19 Sarepta Therapeutics to Present at the Morgan Stanley 17th Annual Global Healthcare Conference 8/30/19 Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) 8/19/19 Sarepta Therapeutics Receives Complete Response Letter from the US Food and Drug Administration for Golodirsen New Drug Application 8/8/19 Sarepta Therapeutics Comments on Erroneous Submission to US FDA Adverse Event Reporting System (FAERS) 8/7/19 Sarepta Therapeutics Announces Second Quarter 2019 Financial Results and Recent Corporate Developments 7/31/19 Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) 7/31/19 Sarepta Therapeutics to Announce Second Quarter 2019 Financial Results and Recent Corporate Developments on August 7, 2019 6/28/19 Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) 6/4/19 Sarepta Therapeutics to Present at the Goldman Sachs 40th Annual Global Healthcare Conference 5/31/19 Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Pagination First page « first Previous page ‹ previous … Page 5 Page 6 Page 7 Page 8 Current page 9 Page 10 Page 11 Page 12 Page 13 … Next page next › Last page last » Displaying 81 - 90 of 670